Latest Strategic Development News

Page 10 of 21
Radiopharm Theranostics reported a dramatic revenue surge to $3.63 million alongside a 20% reduction in net loss for FY2025, while increasing its stake in Radiopharm Ventures to 75%.
Ada Torres
Ada Torres
29 Aug 2025
Virgin Australia reported a 3% revenue increase and a 28% rise in underlying EBIT for FY25, while statutory net profit fell 12% due to IPO and Qatar Airways transaction costs. The airline expanded its fleet and loyalty program amid ongoing transformation efforts.
Victor Sage
Victor Sage
29 Aug 2025
333D Limited has reported a remarkable turnaround for the year ended June 2025, posting a profit after tax of $143,777 on the back of a 426% revenue increase driven by its digital asset management strategy. The company also adopted a Bitcoin Treasury Management Policy, signaling a new phase in its financial approach.
Sophie Babbage
Sophie Babbage
28 Aug 2025
Energy Technologies Limited reported a $11 million net loss for FY2025, reflecting a strategic pivot and ongoing capital challenges. Despite a 37% revenue drop, management highlights operational resilience and plans to stabilise through capital management.
Victor Sage
Victor Sage
28 Aug 2025
EMVision Medical Devices reported a sharp increase in FY25 losses alongside a 51% revenue drop, yet marked significant progress in clinical trials for its innovative brain scanners and secured $8 million in government grants to fuel commercialisation.
Ada Torres
Ada Torres
28 Aug 2025
Medallion Metals has significantly expanded its sulphide Mineral Resource Estimate at the Ravensthorpe Gold Project to 950,000 ounces gold equivalent, underpinning a rapid move toward production with a feasibility study due in October and a Final Investment Decision expected by year-end.
Maxwell Dee
Maxwell Dee
28 Aug 2025
Wesfarmers Limited reported a robust 2025 financial year with a 14.4% increase in net profit after tax to $2.926 billion and declared fully franked dividends of $2.06 per share. The conglomerate also unveiled a proposed $1.50 per share capital management distribution, pending shareholder approval.
Victor Sage
Victor Sage
28 Aug 2025
Nova Eye Medical has reported a record A$29.3 million in FY25 revenue, driven by sustained US growth and operational improvements, setting the stage for breakeven EBITDA in the first half of FY26.
Ada Torres
Ada Torres
27 Aug 2025
RAM Essential Services Property Fund reported solid FY25 results, highlighting portfolio growth, strategic capital recycling, and a clear transition towards a pure healthcare real estate focus.
Eva Park
Eva Park
27 Aug 2025
CVC Limited reports a stable FY2025 profit alongside a robust landbank poised for significant value uplift, targeting a net tangible asset per share of $5.75 through strategic rezoning and development.
Eva Park
Eva Park
26 Aug 2025
Scentre Group reports a 3.2% rise in first-half Funds From Operations to $587 million and upgrades its full-year distribution guidance, reflecting strong retail property performance and strategic growth initiatives.
Eva Park
Eva Park
26 Aug 2025
Platinum Capital Limited reported a 24% drop in net profit for FY2025, underperforming its benchmark, while announcing a strategic withdrawal of a merger scheme and initiating a substantial share buy-back alongside significant board changes.
Claire Turing
Claire Turing
25 Aug 2025